scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CYTO.2011.11.019 |
P698 | PubMed publication ID | 22178716 |
P50 | author | Keith A. Sharkey | Q38328653 |
Nima Rezaei | Q26464741 | ||
P2093 | author name string | Mohammad Bashashati | |
Chun-Qiu Chen | |||
Nasser Ebrahimi Daryani | |||
Christopher N Andrews | |||
Martin A Storr | |||
P433 | issue | 2 | |
P921 | main subject | irritable bowel syndrome | Q838966 |
P304 | page(s) | 201-209 | |
P577 | publication date | 2011-12-16 | |
P1433 | published in | Cytokine | Q15745296 |
P1476 | title | Cytokines and irritable bowel syndrome: where do we stand? | |
P478 | volume | 57 |
Q35590592 | Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome |
Q39311930 | Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis |
Q28079482 | Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability |
Q27011652 | Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis |
Q38209378 | Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis |
Q60043882 | Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study |
Q35517355 | Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial |
Q39166000 | Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome |
Q88086374 | Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines |
Q36001130 | Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? |
Q47095550 | Functional Bowel Disorders Are Associated with a Central Immune Activation |
Q40642008 | Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome |
Q55190074 | Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response. |
Q38447499 | Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. |
Q36194938 | Irritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study |
Q36207200 | Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications |
Q35565145 | Irritable bowel syndrome: an integrated explanatory model for clinical practice |
Q37629670 | Irritable bowel syndrome: emerging paradigm in pathophysiology |
Q26765219 | Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? |
Q48156277 | Pain and somatic symptoms are sequelae of sexual assault: results of a prospective longitudinal study |
Q34415870 | Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection |
Q37099359 | Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas |
Q52716489 | Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study. |
Q93186295 | The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome |
Q38905594 | The Traveling Microbiome |
Q38032174 | The chronic gastrointestinal consequences associated with campylobacter |
Q38588312 | Toward a better understanding of the central consequences of intestinal inflammation |
Q51354980 | Update on military diarrhoea: current status and future plans. |
Q36483008 | Virulence genes and cytokine profile in systemic murine Campylobacter coli infection |
Search more.